ctrl K

Watchlist Price Alert

Akero Therapeutics Inc. (AKRO)

NASDAQ: AKRO · Real-Time Price · USD

56.30

1.27 (2.30%)

At close: Jun 26, 2025, 3:59 PM

56.28

-0.04%

Pre-market: Jun 27, 2025, 04:01 AM EDT

Akero Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	29K	260K	244K	213K	n/a	n/a	n/a
Gross Profit	n/a	-29K	-260K	-244K	-213K	n/a	n/a	n/a
Operating Income	-285.42M	-172.87M	-115.16M	-100.89M	-80.15M	-45.65M	-13.78M	-4.56M
Interest Income	n/a	24.21M	3.86M	109K	947K	1.9M	n/a	n/a
Pretax Income	-252.06M	-151.76M	-112.03M	-100.78M	-79.21M	-43.76M	-81.71M	-4.56M
Net Income	-252.06M	-151.76M	-108.91M	-100.74M	-79.19M	-43.76M	-81.71M	-4.56M
Selling & General & Admin	37.93M	31.07M	29.87M	19.13M	15.24M	8.61M	1.9M	1.08M
Research & Development	247.5M	141.8M	85.28M	81.76M	64.92M	37.05M	11.88M	3.49M
Other Expenses	n/a	n/a	3.86M	109K	947K	1.9M	-67.94M	n/a
Operating Expenses	285.42M	172.87M	115.16M	100.89M	80.15M	45.65M	13.78M	4.56M
Interest Expense	n/a	3.1M	739K	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-98K
Cost & Expenses	n/a	172.87M	115.16M	100.89M	80.15M	45.65M	13.78M	4.56M
Income Tax Expense	n/a	n/a	-3.12M	-41K	-17K	24K	-68.1M	-4.98M
Shares Outstanding (Basic)	67.14M	52.57M	38.98M	34.83M	31.46M	15.07M	21.22M	28.56M
Shares Outstanding (Diluted)	67.14M	52.57M	38.98M	34.83M	31.46M	15.07M	21.22M	28.56M
EPS (Basic)	-3.75	-2.89	-2.79	-2.89	-2.52	-2.9	-3.85	-0.16
EPS (Diluted)	-3.75	-2.89	-2.79	-2.89	-2.52	-2.9	-3.85	-0.16
EBITDA	-285.42M	-148.63M	-111.03M	-100.53M	-78.99M	-45.65M	-68.46M	-232.36K
EBIT	-256.73M	-148.66M	-111.29M	-100.78M	-79.21M	-43.73M	-81.71M	-4.56M
Depreciation & Amortization	-28.7M	29K	260K	244K	213K	-104K	13.78M	4.98M